168 related articles for article (PubMed ID: 21135711)
21. Hormonal and nonhormonal treatment of vasomotor symptoms.
Krause MS; Nakajima ST
Obstet Gynecol Clin North Am; 2015 Mar; 42(1):163-79. PubMed ID: 25681847
[TBL] [Abstract][Full Text] [Related]
22. Adiposity and reporting of vasomotor symptoms among midlife women: the study of women's health across the nation.
Thurston RC; Sowers MR; Chang Y; Sternfeld B; Gold EB; Johnston JM; Matthews KA
Am J Epidemiol; 2008 Jan; 167(1):78-85. PubMed ID: 17881385
[TBL] [Abstract][Full Text] [Related]
23. Standard and low-dose hormone therapy for postmenopausal women--focus on the breast.
Wang PH; Horng HC; Cheng MH; Chao HT; Chao KC
Taiwan J Obstet Gynecol; 2007 Jun; 46(2):127-34. PubMed ID: 17638620
[TBL] [Abstract][Full Text] [Related]
24. Vasomotor flushes in menopausal women.
Bachmann GA
Am J Obstet Gynecol; 1999 Mar; 180(3 Pt 2):S312-6. PubMed ID: 10076170
[TBL] [Abstract][Full Text] [Related]
25. Hormone replacement therapy and beyond. The clinical challenge of menopausal symptoms in breast cancer survivors.
Mortimer JE
Geriatrics; 2002 Sep; 57(9):25-31. PubMed ID: 12271826
[TBL] [Abstract][Full Text] [Related]
26. Hormone alternative doesn't worsen vasomotor symptoms or impact urinary incontinence in post-menopausal women.
Rollins G
Rep Med Guidel Outcomes Res; 2004 Mar; 15(5):7-9. PubMed ID: 15025087
[No Abstract] [Full Text] [Related]
27. Climacteric: concept, consequence and care.
Taechakraichana N; Jaisamrarn U; Panyakhamlerd K; Chaikittisilpa S; Limpaphayom KK
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S1-15. PubMed ID: 12188398
[TBL] [Abstract][Full Text] [Related]
28. Duration of vasomotor symptoms in middle-aged women: a longitudinal study.
Col NF; Guthrie JR; Politi M; Dennerstein L
Menopause; 2009; 16(3):453-7. PubMed ID: 19188852
[TBL] [Abstract][Full Text] [Related]
29. The complex interplay of vasomotor symptoms, hormone therapy, and cardiovascular risk.
Allison MA; Manson JE
Menopause; 2009; 16(4):619-20. PubMed ID: 19503007
[No Abstract] [Full Text] [Related]
30. Neurokinin 3 receptor antagonism - Is this the end of HRT?
Simpson P; Currie H; Morris E
Post Reprod Health; 2018 Jun; 24(2):61-62. PubMed ID: 29925302
[No Abstract] [Full Text] [Related]
31. Managing vasomotor symptoms effectively without hormones.
McCormick CA; Brennan A; Hickey M
Climacteric; 2020 Dec; 23(6):532-538. PubMed ID: 32696683
[TBL] [Abstract][Full Text] [Related]
32. Modeling women's health during the menopausal transition: a longitudinal analysis.
Dennerstein L; Lehert P; Guthrie JR; Burger HG
Menopause; 2007; 14(1):53-62. PubMed ID: 17023873
[TBL] [Abstract][Full Text] [Related]
33. Vasomotor symptoms, estradiol levels and cardiovascular risk profile in women.
Gast GC; Samsioe GN; Grobbee DE; Nilsson PM; van der Schouw YT
Maturitas; 2010 Jul; 66(3):285-90. PubMed ID: 20400247
[TBL] [Abstract][Full Text] [Related]
34. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
[TBL] [Abstract][Full Text] [Related]
35. The hot flush: the enigma of the climacteric.
Sturdee DW
Climacteric; 2001 Mar; 4(1):1-3. PubMed ID: 11379372
[No Abstract] [Full Text] [Related]
36. Nonestrogen treatment modalities for vasomotor symptoms associated with menopause.
Fugate SE; Church CO
Ann Pharmacother; 2004 Sep; 38(9):1482-99. PubMed ID: 15292498
[TBL] [Abstract][Full Text] [Related]
37. Femal, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study.
Winther K; Rein E; Hedman C
Climacteric; 2005 Jun; 8(2):162-70. PubMed ID: 16096172
[TBL] [Abstract][Full Text] [Related]
38. Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies.
Keenan NL; Mark S; Fugh-Berman A; Browne D; Kaczmarczyk J; Hunter C
Menopause; 2003; 10(6):507-15. PubMed ID: 14627858
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of black cohosh-containing preparations on menopausal symptoms: a meta-analysis.
Shams T; Setia MS; Hemmings R; McCusker J; Sewitch M; Ciampi A
Altern Ther Health Med; 2010; 16(1):36-44. PubMed ID: 20085176
[TBL] [Abstract][Full Text] [Related]
40. Estrasorb.
Chiechi LM
IDrugs; 2004 Sep; 7(9):860-4. PubMed ID: 15470604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
